4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001192482-21-000119
Options or other derivatives
- Chief Executive Officer acquired 850,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
COLA MICHAEL F · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-01-26 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +850,000 | $3.32 | 2031-01-26 | 850,000 | 850,000 | D |
Loading xslF345X03/edgar.xml…